Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
This Week in The Journal

This Week in The Journal

Teresa Esch [Ph.D.]
Journal of Neuroscience 12 January 2022, 42 (2) 155; https://doi.org/10.1523/JNEUROSCI.twij.42.2.2022
Teresa Esch
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Hypocretin Contributes to Morphine Withdrawal Symptoms

Ronald McGregor, Ming-Fung Wu, Brent Holmes, Hoa Anh Lam, Nigel T. Maidment, et al.

(see pages 255–263)

Repeated use of heroin, cocaine, or related drugs can produce long-lasting changes in multiple brain areas, thus promoting continued drug use despite negative consequences. One area affected by these drugs is the lateral hypothalamus, which houses neurons that produce hypocretin (also called orexin). These neurons help drive goal-directed behaviors in response to internal states (such as hunger) or external stimuli that signal the availability of reward, including drugs of abuse. Drug-associated stimuli increase the activity of hypocretin neurons, and remarkably, the number of hypocretin-expressing neurons is much higher in people addicted to heroin than in control subjects. Similarly, chronic morphine administration increases the number of hypocretin-expressing neurons in rodent hypothalamus, presumably by increasing hypocretin levels in neurons that previously produced this peptide at undetectable levels.

Given that hypocretin neurons project throughout the brain, increases in hypocretin expression may have wide-ranging downstream effects. Investigating these effects in mice, McGregor et al. focused on three brainstem areas that produce norepinephrine and are thought to contribute to unpleasant consequences of withdrawal: the locus coeruleus and the A1 and A2 clusters. Daily injections of morphine for 2 weeks approximately doubled the density of hypocretin-expressing fibers and significantly increased the expression of tyrosine hydroxylase (required for norepinephrine synthesis) in the locus coeruleus. In contrast, morphine did not affect hypocretin innervation or tyrosine hydroxylase levels in A1/A2 clusters. Importantly, tyrosine hydroxylase did not increase in the locus coeruleus if hypocretin neurons were killed before morphine treatment. Furthermore, although killing hypocretin neurons did not prevent mice from developing a preference for a chamber paired with morphine administration, it reduced locomotor sensitization to morphine, reduced physical and affective symptoms of withdrawal, and prevented the development of conditioned aversion to a chamber paired with naloxone treatment after chronic morphine administration.

These results suggest that chronic morphine treatment increases hypocretin release and tyrosine hydroxylase production selectively in the locus coeruleus, possibly resulting in increased norepinephrine release in target areas. Future work should determine where norepinephrine release increases and the extent to which this is required for the development of withdrawal symptoms. Finally, the results add to evidence suggesting that targeting the hypocretin system may reduce withdrawal symptoms and thus reduce relapse in people addicted to opiates.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

After mice receive morphine for 14 d (right), the density of hypocretin-expressing axons (green) and the expression of tyrosine hydroxylase (red) in the locus coeruleus are much higher than normal (left). See McGregor et al. for details.

Exercise Reduces Inflammatory Microglia in Brain

Kaitlin B. Casaletto, Cutter A. Lindbergh, Anna VandeBunte, John Neuhaus, Julie A. Schneider, et al.

(see pages 288–298)

Brain damage resulting from concussion, blood vessel blockage, infections, and even normal aging processes leads to activation of microglia, which initiate inflammatory responses. Although these responses are important for clearing debris and repairing damage, chronic inflammation is detrimental and contributes to neurodegenerative diseases. Blocking the destructive effects of microglia while maintaining the beneficial effects may therefore help to slow disease progression and promote healthy aging. Remarkably, studies in animals have suggested that this goal might be achieved through exercise. In support of this, Casaletto et al. show that microglial activation in some brain areas is inversely correlated with physical activity levels, particularly in people with inflammatory conditions.

The authors examined postmortem brain tissue from elderly volunteers who had undergone yearly assessments of activity level, motor function, and cognition before they died. Immunostaining and morphological assessment were used to determine the proportion of microglia that were highly activated in different brain areas, and levels of synaptic proteins and pathological hallmarks of several neurodegenerative conditions were quantified. Bivariate correlation analysis indicated that activity levels were inversely related to the proportion of activated microglia in the caudate and the inferior temporal gyrus, and these relationships were strongest in brains with evidence of infarcts and high levels of Alzheimer's disease (AD) pathology, respectively. Microglial activation in the caudate was unrelated to synaptic protein levels or cognition, but microglial activation in the inferior temporal gyrus was inversely related to both of these measures. Moreover, mediation analysis indicated that reductions in the proportion of activated microglia in the inferior temporal gyrus partly accounted for the positive relationship between physical activity and both synaptic protein levels and cognitive function in people with high levels of AD-related pathology.

These results suggest that increasing physical activity can reduce detrimental microglial activation in people with AD pathology and thus can reduce synaptic damage and cognitive decline. Notably, many people exhibit AD-related pathology without behavioral symptoms; staying active may make such people resilient to cognitive consequences. Together with previous studies showing that exercise generally enhances cognition and mood, this work should help motivate people to keep their resolution to get more exercise.

Footnotes

  • This Week in The Journal was written by Teresa Esch, Ph.D.

Back to top

In this issue

The Journal of Neuroscience: 42 (2)
Journal of Neuroscience
Vol. 42, Issue 2
12 Jan 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
This Week in The Journal
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
This Week in The Journal
Journal of Neuroscience 12 January 2022, 42 (2) 155; DOI: 10.1523/JNEUROSCI.twij.42.2.2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
This Week in The Journal
Journal of Neuroscience 12 January 2022, 42 (2) 155; DOI: 10.1523/JNEUROSCI.twij.42.2.2022
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Hypocretin Contributes to Morphine Withdrawal Symptoms
    • Exercise Reduces Inflammatory Microglia in Brain
    • Footnotes
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • This Week in The Journal
  • This Week in The Journal
  • This Week in The Journal
Show more This Week in The Journal
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.